Arbutus Biopharma | Investor Presentation Deck | 26 slides · page 22 of 26
Includes both in vitro (IFN-y fold increase) and in vivo (MC38 tumor model) efficacy data.
Pitch deck · traction · show_traction · balanced density
Slide locked Sign in to view
Slide schematic 5/5
callout 1/1 chart 2/2 source-note 1/1 title 1/1
Components 5
primary bar-vertical line source-note headline
Tools 1
Metrics 0
∅
No metrics
No metric insight is anchored to this slide.
Frameworks 0
∅
No frameworks
No framework match is anchored to this slide.